Back to top
more

Bruker (BRKR)

(Real Time Quote from BATS)

$61.27 USD

61.27
150,631

+0.06 (0.10%)

Updated Jul 10, 2024 02:22 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 250)

Industry: Instruments - Scientific

Better trading starts here.

Zacks News

Will Bruker (BRKR) Beat Estimates Again in Its Next Earnings Report?

Bruker (BRKR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Bruker (BRKR) Banks on End Market Growth Amid Macro Headwinds

Bruker's (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand.

Bruker (BRKR) Expands in NMR Spectrometry With New FMP Collab

Bruker (BRKR) completes the installation of its 1.2 (GHz) Avance nuclear magnetic resonance (NMR) spectrometer at the Leibniz Forschungsinstitut f??r Molekulare Pharmakologie in Berlin.

Bruker's (BRKR) Strategic Buyouts Aid Amid Macroeconomic Woes

Bruker's (BRKR) NANO Life Science fluorescence microscopy is gaining from product innovation and research demand, further bolstered by the addition of Inscopix's neuroscience research tools.

Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now?

Smart Beta ETF report for FBT

Bruker (BRKR) Launches neofleX MALDI-TOF/TOF MSI System

Bruker's (BRKR) neofleX is a versatile, high-performance and easy-to-use multiomics MSI system for biopharma, translational and clinical researchers.

Bruker (BRKR) Gains Market Share on Innovation Amid Macro Woes

Bruker's (BRKR) BSI Nano business is seeing robust revenue growth across its end markets, including academic, government, industrial and semiconductor metrology.

Zacks Industry Outlook Highlights Mettler-Toledo and Bruker

Mettler-Toledo and Bruker have been highlighted in this Industry Outlook article.

Aniruddha Ganguly headshot

2 Instruments Stocks to Watch From a Prospering Industry

The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD) and Bruker (BRKR) are gaining from strong life science, pharmaceutical and academic end-market demand despite the challenging macroeconomic environment.

Investing in Bruker (BRKR)? Don't Miss Assessing Its International Revenue Trends

Examine Bruker's (BRKR) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Down -22.53% in 4 Weeks, Here's Why Bruker (BRKR) Looks Ripe for a Turnaround

Bruker (BRKR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Bruker (BRKR) Q1 Earnings Surpass Estimates, Margins Decline

Bruker's (BRKR) BioSpin segment witnessed growth across biopharma, academic government and industrial research in the first quarter of 2024.

Bruker (BRKR) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Bruker (BRKR) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Are Computer and Technology Stocks Lagging Alphabet (GOOGL) This Year?

Here is how Alphabet (GOOGL) and Bruker (BRKR) have performed compared to their sector so far this year.

Bruker (BRKR) Q1 Earnings Beat Estimates

Bruker (BRKR) delivered earnings and revenue surprises of 15.22% and 0.30%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

Urmimala Biswas headshot

Will These 5 MedTech Stocks Beat Forecasts This Earnings Season?

Here is a sneak peek into how the five MedTech stocks, HOLX, ZBH, ILMN, TFX and BRKR, are expected to fare in their quarterly results slated to be released tomorrow.

Countdown to Bruker (BRKR) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Evaluate the expected performance of Bruker (BRKR) for the quarter ended March 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Here's Why You Should Buy Bruker (BRKR) Stock Right Now

Bruker's (BRKR) strong potential across the NANO and BioSpin segments bodes well for investors.

Bruker's (BRKR) Balanced Segmental Growth, Innovation Aid

Bruker (BRKR) revenues continue to be driven by the strength of end markets, including academic, government and industrial.

Earnings Preview: Bruker (BRKR) Q1 Earnings Expected to Decline

Bruker (BRKR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Bruker (BRKR) Introduces Magnet Technology for NMR Adoption

Bruker's (BRKR) latest novel technology facilitates the widespread application of NMR in academic basic and clinical research.

Bruker Corporation (BRKR) Hits 52-Week High: What's Driving It?

Bruker Corporation (BRKR) outperforms the industry due to its strengthening portfolio and robust quarterly results.

Why Is Bruker (BRKR) Up 15.7% Since Last Earnings Report?

Bruker (BRKR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?

Investors are upbeat about Bruker (BRKR) led by strong NANO group prospects and strong guidance.